James Vane
Stock Analyst at Jefferies
(0.82)
# 4,065
Out of 5,000 analysts
484
Total ratings
48.4%
Success rate
-1.3%
Average return
Main Sectors:
Stocks Rated by James Vane
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: SDZ Sandoz Group AG | Reiterated: Buy | CHF 93.00 → CHF 94.00 | CHF 70.78 | +32.81% | 8 | Sep 10, 2026 | |
| ETR: MRK Merck KGaA | Reiterated: Hold | €144.00 | €133.95 | +7.50% | 7 | Sep 3, 2026 | |
| LON: HIK Hikma Pharmaceuticals PLC | Reiterated: Buy | 1,870p → 2,025p | 1,625p | +24.62% | 28 | Aug 25, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Reiterated: Hold | €17.30 | €24.25 | -28.66% | 10 | Aug 12, 2026 | |
| ETR: FME Fresenius Medical Care AG | Reiterated: Sell | €31.00 → €30.00 | €39.35 | -23.76% | 93 | Aug 11, 2026 | |
| ETR: FRE Fresenius SE & Co. KGaA | Reiterated: Buy | €55.00 | €45.74 | +20.26% | 83 | Aug 5, 2026 | |
| EPA: VIRP Virbac SA | Reiterated: Hold | €361.00 → €360.00 | €302.00 | +19.21% | 14 | Jul 31, 2026 | |
| LON: CVSG CVS Group plc | Reiterated: Hold | 1,350p → 1,400p | 1,221p | +14.66% | 18 | Jul 31, 2026 | |
| SWX: LONN Lonza Group AG | Reiterated: Buy | CHF 798.00 → CHF 781.00 | CHF 570.00 | +37.02% | 14 | Jul 28, 2026 | |
| WSE: DIA Diagnostyka S.A. | Reiterated: Hold | zł 188.00 → zł 176.00 | zł 162.60 | +8.24% | 4 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 827p | 490p | +68.78% | 4 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 94.50 → CHF 88.00 | CHF 74.15 | +18.68% | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €83.50 → €64.20 | €59.50 | +7.90% | 9 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 110.00 | CHF 118.96 | -7.53% | 2 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €307.00 | €265.30 | +15.72% | 34 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €210.00 → €246.00 | €209.50 | +17.42% | 2 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €229.00 → €262.00 | €215.80 | +21.41% | 13 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €34.10 | €26.18 | +30.25% | 40 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $21.46 | - | 24 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | CHF 49.30 | CHF 83.05 | n/a | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 260p → 298p | 246p | n/a | 17 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €49.00 → €61.50 | €53.00 | n/a | 3 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $17 → $18 | $22.35 | n/a | 8 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9.3 → $11 | $13.10 | n/a | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €4.49 | €3.90 | n/a | 7 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €49.00 | €37.21 | n/a | 23 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 147.00 → CHF 148.00 | CHF 96.38 | n/a | 4 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | 300p | 212p | n/a | 1 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €135.00 → €43.00 | €11.57 | n/a | 2 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.05 | n/a | 1 | Dec 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 93.00 | kr 258.50 | n/a | 1 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $31 | $12.30 | n/a | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $43.76 | n/a | 1 | Aug 21, 2017 |
Sandoz Group AG
Sep 10, 2026
Reiterated: Buy
Price Target: CHF 93.00 → CHF 94.00
Current: CHF 70.78
Upside: +32.81%
Merck KGaA
Sep 3, 2026
Reiterated: Hold
Price Target: €144.00
Current: €133.95
Upside: +7.50%
Hikma Pharmaceuticals PLC
Aug 25, 2026
Reiterated: Buy
Price Target: 1,870p → 2,025p
Current: 1,625p
Upside: +24.62%
SCHOTT Pharma AG & Co. KGaA
Aug 12, 2026
Reiterated: Hold
Price Target: €17.30
Current: €24.25
Upside: -28.66%
Fresenius Medical Care AG
Aug 11, 2026
Reiterated: Sell
Price Target: €31.00 → €30.00
Current: €39.35
Upside: -23.76%
Fresenius SE & Co. KGaA
Aug 5, 2026
Reiterated: Buy
Price Target: €55.00
Current: €45.74
Upside: +20.26%
Virbac SA
Jul 31, 2026
Reiterated: Hold
Price Target: €361.00 → €360.00
Current: €302.00
Upside: +19.21%
CVS Group plc
Jul 31, 2026
Reiterated: Hold
Price Target: 1,350p → 1,400p
Current: 1,221p
Upside: +14.66%
Lonza Group AG
Jul 28, 2026
Reiterated: Buy
Price Target: CHF 798.00 → CHF 781.00
Current: CHF 570.00
Upside: +37.02%
Diagnostyka S.A.
Jul 13, 2026
Reiterated: Hold
Price Target: zł 188.00 → zł 176.00
Current: zł 162.60
Upside: +8.24%
Jun 2, 2026
Reiterated: Buy
Price Target: 827p
Current: 490p
Upside: +68.78%
May 13, 2026
Reiterated: Hold
Price Target: CHF 94.50 → CHF 88.00
Current: CHF 74.15
Upside: +18.68%
May 13, 2026
Reiterated: Hold
Price Target: €83.50 → €64.20
Current: €59.50
Upside: +7.90%
Apr 28, 2026
Reiterated: Hold
Price Target: CHF 110.00
Current: CHF 118.96
Upside: -7.53%
Apr 23, 2026
Reiterated: Buy
Price Target: €307.00
Current: €265.30
Upside: +15.72%
Mar 18, 2026
Reiterated: Buy
Price Target: €210.00 → €246.00
Current: €209.50
Upside: +17.42%
Mar 17, 2026
Reiterated: Buy
Price Target: €229.00 → €262.00
Current: €215.80
Upside: +21.41%
Feb 2, 2026
Reiterated: Buy
Price Target: €34.10
Current: €26.18
Upside: +30.25%
Jan 16, 2026
Reiterated: Hold
Price Target: n/a
Current: $21.46
Upside: -
Sep 25, 2025
Initiated Coverage: Sell
Price Target: CHF 49.30
Current: CHF 83.05
Upside: n/a
Aug 15, 2025
Reiterated: Buy
Price Target: 260p → 298p
Current: 246p
Upside: n/a
Aug 11, 2025
Upgraded: Buy
Price Target: €49.00 → €61.50
Current: €53.00
Upside: n/a
Aug 8, 2024
Reiterated: Sell
Price Target: $17 → $18
Current: $22.35
Upside: n/a
May 14, 2024
Reiterated: Buy
Price Target: $9.3 → $11
Current: $13.10
Upside: n/a
Jan 5, 2024
Reiterated: Hold
Price Target: €4.49
Current: €3.90
Upside: n/a
Nov 8, 2023
Reiterated: Hold
Price Target: €49.00
Current: €37.21
Upside: n/a
Feb 23, 2023
Reiterated: Buy
Price Target: CHF 147.00 → CHF 148.00
Current: CHF 96.38
Upside: n/a
Nov 22, 2022
Initiated Coverage: Buy
Price Target: 300p
Current: 212p
Upside: n/a
Jan 28, 2022
Downgraded: Hold
Price Target: €135.00 → €43.00
Current: €11.57
Upside: n/a
Dec 5, 2019
Downgraded: Hold
Price Target: n/a
Current: $10.05
Upside: n/a
Nov 1, 2018
Reiterated: Buy
Price Target: kr 93.00
Current: kr 258.50
Upside: n/a
Nov 1, 2017
Reiterated: Sell
Price Target: $31
Current: $12.30
Upside: n/a
Aug 21, 2017
Upgraded: Hold
Price Target: n/a
Current: $43.76
Upside: n/a